On the latest episode of Let's Talk ETFs, we take a look at the Amplify Seymour Alternative Plant Economy ETF (CNBS). CNBS' manager, Tim Seymour, who also hosts CNBC Fast Money lays out the long-term bullish case for this sector while trying to make sense of its terrible performance YTD. We want to wish a Happy Thanksgiving to all of our listeners!
Topics include:

2:00 - Tim's backstory: What drew him to cannabis investing?

13:00 - Launching the Amplify Seymour Cannabis ETF, and Tim's Fast Money platform.

20:00 - After so much carnage in the space, are Cannabis sector valuations finally more reasonable?

27:30 - What did prognosticators like Deloitte get wrong in the lead-up to legalization in Canada and California?

37:30 - How does Tim get access to US markets via CNBS and when does he see investors being able to profit from markets beyond Canada?

50:45 - How is CNBS structured and how does Tim value stocks in the space?

1:01:00 - Effect of Bruce Linton firing on Canopy Growth Corporation (CGC).

1:09:45 - Which companies are best positioned for global growth? (ACB)

1:15:30 - Stock recommendation: MediPharm Labs (OTCQX:MEDIF) [TSE:LABS]

1:17:30 - Concluding remarks: Where's the industry headed?


Learn more about your ad choices. Visit megaphone.fm/adchoices